PATENT CLAIM ANALYSIS

Application Number: 16202637
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "304000"]

Abstract:
The invention provides methods for modulating the activity of farnesoid X receptors (FXRs) using specific doses of tropifexor, in particular for treating or preventing liver diseases.

Claim (Index 7):
A pharmaceutical unit dosage form composition comprising about 140 \u03bcg, about 1500 \u03bcg, about 160 \u03bcg, about 170 \u03bcg, about 180 \u03bcg, about 190 \u03bcg, about 200 \u03bcg about 210 \u03bcg, about 220 \u03bcg, about 230 \u03bcg, about 240 \u03bcg or about 250 \u03bcg of tropifexor suitable for oral administration up to a maximum total dose of about 500 \u03bcg per day.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 98.0
- Lexical Diversity: 1.07143
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16030141', '11081002', '15139138', '15299559', '16335662']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7779261619995722
- 35 USC 102 Novelty (BERT): 0.5251158525409261
- Combined Prediction Score: 0.7526451310537076
- Mean Citation Score: 321.56227
- Max Citation Score: 330.3247
- Similarity Product: 206.0510873284936

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test